Table 2.
Estimated 5-year survival rates by Kaplan-Meier method.
| Endometrial Cancer | Ovarian Cancer | |||||
|---|---|---|---|---|---|---|
| n (%) | PFS after 5 years [%], p value | OS after 5 years [%], p value | n (%) | PFS after 5 years [%], p value | OS after 5 years [%], p value | |
|
Red blood cell (RBC) transfusions
non-transfused transfused |
152 133 (87.5) 19 (12.5) |
<0.001
79.8 26.0 |
<0.001
82.6 25.7 |
111 54 (48.6) 57 (51.4) |
0.738 40.8 26.0 |
0.073
46.3 20.8 |
|
Preoperative anemia of cancer (AOC)
non-anemic anemic |
151 116 (76.8) 35 (23.2) |
0.110 77.2 65.0 |
<0.001
81.2 57.1 |
110 72 (65.5) 38 (34.5) |
0.088
39.5 26.9 |
0.008
36.7 10.6 |
|
G8 geriatric Screening tool (G8 Score)
G8-non-frail G8-frail |
150 92 (61.3) 58 (38.7) |
0.071
82.1 65.4 |
<0.001
88.2 49.7 |
110 56 (50.9) 54 (49.1) |
0.010
53.4 16.7 |
0.149 40.5 15.3 |
|
Frail – RBC transfusions
G8-non-frail + non-transfused G8-non-frail + transfused G8-frail + non-transfused G8-frail + transfused |
148 87 3 43 15 |
0.003
86.0 66.7 72.4 39.2 |
<0.001
90.2 33.3 61.3 17.3 |
99 38 (38.4) 13 (13.1) 27 (27.3) 21 (21.2) |
0.039
47.2 77.8 22.3 17.0 |
0.170 45.5 27.8 14.6 14.6 |
AOC, anemia of cancer; OS, overall survival; PFS, progression free survival; RBC, red blood cell.
n = number of patients; G8 frail: G8 geriatric Screening tool > 14 points, G8 non-frail: G8 geriatric Screening tool ≤ 14 points
bold written words: analyzed main categories;
bold written numbers: statistically significant results (p<0.05); italic written numbers: clinically relevant results (p<0.1).